LHRH-agonist treatment in metastatic prostate carcinoma

This publication has 29 references indexed in Scilit:

• Advanced carcinoma of the prostate: treatment with a gonadotrophin releasing hormone agonist.
  BMJ, 1983
• Treatment with gonadotrophin releasing hormone analogue in advanced prostatic cancer.
  BMJ, 1983
• The presence of LHRH‐like receptors in Dunning R3327H prostate tumors
  FEBS Letters, 1983
• SUSTAINED SUPPRESSION OF TESTOSTERONE PRODUCTION BY THE LUTEINISING-HORMONE RELEASING-HORMONE AGONIST BUSERELIN IN PATIENTS WITH ADVANCED PROSTATE CARCINOMA
  The Lancet, 1982
• TREATMENT WITH A LUTEINISING-HORMONE-RELEASING-HORMONE ANALOGUE (BUSERELIN) IN PREMENOPAUSAL PATIENTS WITH METASTATIC BREAST CANCER
  The Lancet, 1982
• Effect of chronic administration of a highly potent LHRH agonist on prostate size and secretory function in geriatric dogs
  The Prostate, 1982
• Sertoli–Leydig cell communication via an LHRH-like factor
  Nature, 1981
• Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: A new biological effect
  Life Sciences, 1981
• Reduction of LH-RH pituitary and estradiol uterine binding sites by a superactive analog of luteinizing hormone-releasing hormone
  Biochemical and Biophysical Research Communications, 1980
• THE IMPORTANCE OF PITUITARY TUMOUR SIZE IN PATIENTS WITH HYPERPROLACTINAEMIA IN RELATION TO HORMONAL VARIABLES AND EXTRASELLAR EXTENSION OF TUMOUR
  Clinical Endocrinology, 1980